Latest Research Reports On Stocks By Leading Brokerages: If you have any research reports that you would like to share with us, please send it to michael@rakesh-jhunjhunwala.in or to admin@rakesh-jhunjhunwala.in. (The pre-June 2016 reports are available here).
Neogen Chemicals Ltd: Research Report By Edelweiss | |
Company: | Neogen Chemicals |
Brokerage: | Edelweiss |
Date of report: | December 3, 2020 |
Type of Report: | Initiating Coverage |
Recommendation: | Buy |
Upside Potential: | 22% |
Summary: | Transitioning into a CSM player |
Full Report: | Click here to view full post with link to download pdf file |
Tags: | Edelweiss, Neogen Chemicals |
Buy Laurus Labs For 40% Gain: Research Report By Motilal Oswal | |
Company: | Laurus Labs |
Brokerage: | Motilal Oswal |
Date of report: | December 1, 2020 |
Type of Report: | Result Update |
Recommendation: | Buy |
Upside Potential: | 40% |
Summary: | Richcore acquisition – A step towards strategic diversification |
Full Report: | Click here to view full post with link to download pdf file |
Tags: | Laurus Labs, Motilal Oswal |
Dalmia Bharat Ltd: Strong Buy Recommendation By SMIFS | |
Company: | Dalmia Bharat Ltd |
Brokerage: | Stewart & Mackertich |
Date of report: | October 9, 2020 |
Type of Report: | Initiating Coverage |
Recommendation: | Buy |
Upside Potential: | 32% |
Summary: | Company is well-poised for a re-rating given growth visibility, improving balance sheet and attractive valuation |
Full Report: | Click here to view full post with link to download pdf file |
Tags: | Dalmia Bharat Ltd, Stewart & Mackertich |
Gillette India Research Report By Nirmal Bang | |
Company: | Gillette India |
Brokerage: | Nirmal Bang |
Date of report: | November 29, 2020 |
Type of Report: | Result Update |
Recommendation: | Buy |
Upside Potential: | 3% |
Summary: | We expect strong growth in FY21 on a low base |
Full Report: | Click here to view full post with link to download pdf file |
Tags: | Gillette India, Nirmal Bang |
Godrej Properties: Initiating Coverage Research Report By HDFC Securities | |
Company: | Godrej Properties |
Brokerage: | HDFC Sec |
Date of report: | November 27, 2020 |
Type of Report: | Initiating Coverage |
Recommendation: | Buy |
Upside Potential: | 5% |
Summary: | The housing factory |
Full Report: | Click here to view full post with link to download pdf file |
Tags: | Godrej Properties, HDFC Sec |
Advanced Enzyme Technologies Research Report By ICICI Direct | |
Company: | Advanced Enzyme Technologies |
Brokerage: | ICICI-Direct |
Date of report: | November 26, 2020 |
Type of Report: | Initiating Coverage |
Recommendation: | Buy |
Upside Potential: | 28% |
Summary: | Specialised business model with high entry barriers |
Full Report: | Click here to view full post with link to download pdf file |
Tags: | Advanced Enzyme Technologies, ICICI-Direct |
Sundram Fasteners Initiating Coverage Research Report By HDFC Sec | |
Company: | Sundram Fasteners |
Brokerage: | HDFC Sec |
Date of report: | November 25, 2020 |
Type of Report: | Initiating Coverage |
Recommendation: | Buy |
Upside Potential: | 12% |
Summary: | Fastening growth |
Full Report: | Click here to view full post with link to download pdf file |
Tags: | HDFC Sec, Sundram Fasteners |
Kalpataru Power Transmission Ltd Research Report By Edelweiss | |
Company: | Kalpataru Power Transmission Ltd |
Brokerage: | Edelweiss |
Date of report: | November 24, 2020 |
Type of Report: | Initiating Coverage |
Recommendation: | Buy |
Upside Potential: | 70% |
Summary: | Five factors that make it a compelling Tactical BUY |
Full Report: | Click here to view full post with link to download pdf file |
Tags: | Edelweiss, Kalpataru Power Transmission Ltd |
Solara Active Pharma Sciences Initiating Coverage Research Report Of Axis Securities | |
Company: | Solara Active Pharma Sciences Ltd |
Brokerage: | Axis Securities |
Date of report: | November 24, 2020 |
Type of Report: | Initiating Coverage |
Recommendation: | Buy |
Upside Potential: | 25% |
Summary: | EMERGING AS A GLOBAL PURE-PLAY API PLAYER |
Full Report: | Click here to view full post with link to download pdf file |
Tags: | Axis Securities, Solara Active Pharma Sciences Ltd |
HIL Ltd – Strong Buy Recommendation By SMIFS For 47% Gain | |
Company: | HIL Ltd |
Brokerage: | Stewart & Mackertich |
Date of report: | November 23, 2020 |
Type of Report: | Initiating Coverage |
Recommendation: | Buy |
Upside Potential: | 47% |
Summary: | Renowned brand with multiple offerings |
Full Report: | Click here to view full post with link to download pdf file |
Tags: | HIL Ltd, Stewart & Mackertich |